Interactive modules by Olga Goodman, MD.Copyright protected · Read termsClose terms

All RheumaView™ interactive modules, quizzes and educational cases are original works developed by Olga Goodman, MD.

Without the author’s prior written permission, you may not copy or republish these modules or their components; extract, reuse or modify their original software code (“engines”); or use that code to build your own modules, quizzes or other products.

You may not claim these works as your own or remove or replace the author’s name or copyright notices. When quoting material, credit Olga Goodman, MD, identify the source and include a direct link to the original.

Free or public access is provided for learning and does not grant permission to copy, adapt or redistribute the materials. Unauthorized use of protected material may constitute copyright infringement. Exceptions and limitations provided by applicable law remain unaffected.

Sharing direct links to the modules is welcome.

© 2026 Olga Goodman, MD. All rights reserved.

Rheumatology in Perspective · by Olga Goodman, MD · A RheumaView publication

For young people and families · Patient chapter

Infections, Vaccines, and Treatment Safety

Build a medicine-specific safety plan before it is needed: routine checks, illness and vaccine advice, urgent contact routes, and practical arrangements for school, travel and growing independence.

Open accessChapter 13Sources checked 10 October 2026

On this page

Safety is a shared plan, not a list to memorize

A safety plan should support everyday life. Know what to watch for, whom to contact and which instructions apply to the exact medicine.

Infection risk depends on the treatment, disease activity and the child’s other health conditions. Ask for written advice that names the drug and explains what to do during illness, after a missed treatment and before a vaccine or procedure.

Before treatment, check the starting information

The team may review previous infections, vaccinations, travel or tuberculosis exposure and arrange tests appropriate to the proposed medicine. Tuberculosis screening is recommended before biologic treatment in children with JIA; later reassessment depends on exposure concerns and the clinical plan. Report new exposure even after a previous negative test.

Bring the vaccination record, medicine list and details of past allergic reactions. Ask which results need review before treatment and who will contact the family. Every child does not need every infection test.

Routine checks continue when the child feels well

Blood tests may look for effects on blood cells, the liver or kidneys. Other checks depend on the medicine. Agree who arranges the tests, where the results go and what happens if an appointment or result is missed.

Report recurring nausea or other troublesome effects before treatment becomes impossible. Use the agreed advice route for mild familiar problems. New, worsening or unusual symptoms deserve a fresh assessment rather than being filed automatically under “side effects”.

When to seek advice today

If the child takes medicine that suppresses or modifies the immune system, use the team’s illness plan and seek same-day advice for fever or suspected infection. Tell the clinician the drug names and when treatment was last given. Do not wait for the rheumatology appointment if the child needs assessment by a local service.

Also seek same-day advice about unexplained bruising or bleeding, new mouth ulcers with illness, marked reduction in drinking or urination, or a suspected important medicine reaction. After possible exposure to chickenpox, shingles or measles, contact the treating or local pediatric team promptly, even if the child currently feels well; preventive treatment can be time-sensitive. If infection is suspected, phone the service before arriving so it can advise on safe attendance.

When waiting for a reply is unsafe

Use local emergency services now for severe breathing difficulty, sudden swelling of the lips, tongue or throat, collapse, a child who is difficult to wake, blue, grey or unusually pale or blotchy skin, lips or tongue, a rash that does not fade with pressure, or rapid deterioration that makes you fear the child is seriously ill. These can signal a serious allergic reaction or severe illness. The child does not need to have every sign or a measured fever.

Do not leave an urgent message and wait when emergency help is needed. Bring the medicine list or packaging if readily available, but do not delay care to find paperwork.

Keep vaccination on the care plan

Vaccination helps prevent infections that may be more difficult during immune-modifying treatment. The specialist should review the child’s national vaccination schedule and individual needs, including routine adolescent protection such as HPV vaccination. Non-live vaccines can generally be given during immunosuppressive treatment, although response and optimal timing may vary.

Inactivated influenza vaccination has a specific place in pediatric rheumatology recommendations. A nasal live influenza vaccine is a different product from the non-live injection. Before any vaccine, tell the service about all current medicines. The rheumatology and vaccination teams should coordinate timing without the family delaying necessary arthritis treatment on its own.

Live vaccines need a specific decision

Live vaccines are generally avoided during immunosuppressive treatment, but this is not an absolute rule for every child, vaccine and medicine. Pediatric EULAR/PReS guidance describes selected circumstances in which an MMR booster or varicella vaccine may be considered under specialist supervision.

These exceptions are not permission to book a live vaccine without checking. Ask the treating team and vaccination service to agree whether the particular vaccine is suitable and document the plan. Do not copy a medication pause from an adult vaccination leaflet or another patient’s experience.

A missed treatment needs product-specific advice

There is no universal catch-up rule for these medicines. If a treatment was missed, delayed, vomited or partly lost during an injection, record what happened and contact the pharmacist or treating team. Do not add an extra dose on your own.

If an extra or wrong dose may have been given, especially methotrexate, seek immediate medical advice even if the child seems well. Do not wait for symptoms.

Illness, surgery and vaccination may each require a different plan. Ask who decides whether treatment should be changed and who confirms the next step. Avoid filling a gap in instructions with advice intended for a different drug.

Check new medicines across all services

Show the medicine list to the doctor, dentist and pharmacist before adding a prescription or buying a remedy. Some antibiotics, pain medicines and supplements interact with arthritis treatment. For example, trimethoprim and co-trimoxazole can cause a serious interaction with methotrexate; the prescriber needs to know about methotrexate before choosing an antibiotic.

“Natural” does not establish safety. Report herbal products, vitamins and medicines borrowed from home supplies as carefully as prescribed drugs. The pharmacist can check the ingredients.

Plan ahead for travel and time away from home

Before a school trip or holiday, confirm supplies, the product’s storage requirements, any transport documents and how to obtain advice away from home. Ask early about travel vaccines; the destination and medicine both affect the answer. Do not assume all injection devices tolerate the same time outside refrigeration.

Agree which responsible adult knows the plan, while respecting the young person’s privacy. Keep a prescription record and contact details accessible. If a delivery or insurance problem threatens the next treatment, contact the relevant service early rather than inventing a substitute schedule.

Leave room for questions a teenager may not ask aloud

Ask for private time with the clinician and an explanation of confidentiality where care is provided. Alcohol, smoking, vaping, cannabis, sexual health and pregnancy concerns belong in a treatment-safety conversation. Alcohol can add to methotrexate’s liver risks; adult drinking advice found online is not a plan for a teenager.

Methotrexate can harm a developing pregnancy. Discuss effective contraception and pregnancy planning before there is a problem. If pregnancy may have occurred during treatment, seek prompt medical advice. These conversations should be practical and respectful, with clear access to help rather than assumptions about the young person’s life.

Keep the contact route beside the medicine list

Write down the routine team contact, the out-of-hours advice route and the local emergency number. Ask which service assesses an unwell child when rheumatology is unavailable. A school or another caregiver should know how to use the relevant part of the plan.

Review this information when medicines change and before transfer to adult care. The young person can gradually learn to explain what they take, why monitoring matters and when they need help.

Sources and further reading
  1. ACR 2021 JIA guideline: infection screening, monitoring and immunizations
  2. ACR 2026 JIA summary: current medicine-monitoring recommendations
  3. EULAR/PReS vaccination recommendations for pediatric autoimmune inflammatory rheumatic disease: update 2021
  4. Great Ormond Street Hospital: rheumatology illness, chickenpox contact and vaccination questions
  5. Cambridge University Hospitals: medicine safety for children and young people receiving methotrexate
  6. NHS: methotrexate adverse effects and emergency allergic reactions
  7. NHS: sepsis symptoms and emergency action
  8. NHS: methotrexate interactions with medicines and supplements
  9. ACR: methotrexate — liver and reproductive safety
  10. Cosentyx: current US prescribing information and product-specific storage and administration instructions

Share this page

FacebookLinkedInXWhatsAppTelegram

Topics: Juvenile spondyloarthritisSpondyloarthritis